Dicerna Pharmaceuticals Stock Current Ratio
Dicerna Pharmaceuticals fundamentals help investors to digest information that contributes to Dicerna Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Dicerna Stock. The fundamental analysis module provides a way to measure Dicerna Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dicerna Pharmaceuticals stock.
Dicerna |
Dicerna Pharmaceuticals Company Current Ratio Analysis
Dicerna Pharmaceuticals' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Dicerna Pharmaceuticals Current Ratio | 2.46 X |
Most of Dicerna Pharmaceuticals' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dicerna Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Dicerna Pharmaceuticals has a Current Ratio of 2.46 times. This is 15.46% lower than that of the Healthcare sector and 64.86% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 13.89% lower than that of the firm.
Dicerna Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dicerna Pharmaceuticals' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dicerna Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Dicerna Pharmaceuticals by comparing valuation metrics of similar companies.Dicerna Pharmaceuticals is currently under evaluation in current ratio category among its peers.
Dicerna Fundamentals
Return On Equity | -95.22 | |||
Return On Asset | -10.43 | |||
Profit Margin | (64.53) % | |||
Operating Margin | (62.88) % | |||
Current Valuation | 2.48 B | |||
Shares Outstanding | 77.91 M | |||
Shares Owned By Insiders | 7.43 % | |||
Shares Owned By Institutions | 88.54 % | |||
Number Of Shares Shorted | 4.77 M | |||
Price To Earning | (1.58) X | |||
Price To Book | 27.64 X | |||
Price To Sales | 15.44 X | |||
Revenue | 192.85 M | |||
Gross Profit | (41.08 M) | |||
EBITDA | (116.73 M) | |||
Net Income | (124.44 M) | |||
Cash And Equivalents | 565.51 M | |||
Cash Per Share | 7.26 X | |||
Total Debt | 64.42 M | |||
Debt To Equity | 0.60 % | |||
Current Ratio | 2.46 X | |||
Book Value Per Share | 1.38 X | |||
Cash Flow From Operations | 21.05 M | |||
Short Ratio | 0.84 X | |||
Earnings Per Share | (1.63) X | |||
Number Of Employees | 302 | |||
Beta | 0.79 | |||
Market Capitalization | 2.98 B | |||
Total Asset | 62.95 M | |||
Retained Earnings | (539.14 M) | |||
Working Capital | 49.56 M | |||
Current Asset | 59.38 M | |||
Current Liabilities | 9.82 M | |||
Z Score | 16.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |